Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) shot up 0% during mid-day trading on Friday . The company traded as high as GBX 1,629.64 ($20.51) and last traded at GBX 1,626.79 ($20.47). 8 shares were traded during trading, a decline of 100% from the average session volume of 1,655 shares. The stock had previously closed at GBX 1,626 ($20.46).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The company has a debt-to-equity ratio of 0.04, a quick ratio of 9.27 and a current ratio of 9.42. The business has a 50 day simple moving average of GBX 1,639.41 and a 200-day simple moving average of GBX 1,573.32. The firm has a market cap of £4.81 billion and a price-to-earnings ratio of -1,478.90.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- The Risks of Owning Bonds
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Using the MarketBeat Dividend Yield Calculator
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Investing in Construction Stocks
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
